Compounds > phenyl acetate
Page last updated: 2024-08-23

phenyl acetate and Bronchiolitis, Exudative

phenyl acetate has been researched along with Bronchiolitis, Exudative in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's6 (85.71)24.3611
2020's1 (14.29)2.80

Authors

AuthorsStudies
Avila, D; Baird, K; Cheng, GS; Comis, LE; Cowen, EW; Farthing, DE; Gea-Banacloche, JC; Gress, RE; Hakim, FT; Justus, DG; Lee, SJ; Manning-Geist, BL; Martin, PJ; Mitchell, SA; Pavletic, SZ; Rose, J; Steinberg, SM; Williams, KM1
Demeyer, H; Dupont, LJ; Ruttens, D; Van Raemdonck, DE; Vanaudenaerde, BM; Verleden, GM; Verleden, SE; Vos, R; Yserbyt, J1
Burns, L; Chai, X; Cheng, GS; Chien, JW; Flowers, MED; Ho, VT; Inamoto, Y; Jacobsohn, DA; Jagasia, M; Johnston, L; Lee, SJ; Martin, PJ; Mayer, S; Palmer, J; Pavletic, SZ; Pidala, J; Pusic, I; Storer, BE; Williams, KM1
Kim, HJ; Kim, SW; Kim, YJ; Lee, JW; Lee, S; Rhee, CK1
Burns, L; Cheng, GS; Chien, JW; Crothers, K; Ho, VT; Hubbard, JJ; Jagasia, M; Johnston, L; Lee, SJ; Mayer, S; Palmer, J; Pidala, J; Pusic, I; Storer, B; Williams, KM1
Au, BK; Au, MA; Chien, JW; Jacobsohn, DA; Lee, SJ; Moravec, CK; Norman, BC; Williams, KM1
De Vleeschauwer, SI; Dupont, LJ; Van Raemdonck, DE; Vanaudenaerde, BM; Verleden, GM; Verleden, SE; Vos, R1

Trials

3 trial(s) available for phenyl acetate and Bronchiolitis, Exudative

ArticleYear
Prospective Phase II Trial of Montelukast to Treat Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation and Investigation into Bronchiolitis Obliterans Syndrome Pathogenesis.
    Transplantation and cellular therapy, 2022, Volume: 28, Issue:5

    Topics: Acetates; Bronchiolitis Obliterans; Cyclopropanes; Hematopoietic Stem Cell Transplantation; Humans; Prospective Studies; Quinolines; Sulfides; Syndrome

2022
Montelukast for bronchiolitis obliterans syndrome after lung transplantation: A randomized controlled trial.
    PloS one, 2018, Volume: 13, Issue:4

    Topics: Acetates; Bronchiolitis Obliterans; Cyclopropanes; Double-Blind Method; Female; Forced Expiratory Volume; Graft Rejection; Humans; Leukotriene Antagonists; Lung; Lung Transplantation; Male; Middle Aged; Quinolines; Respiratory Function Tests; Sulfides; Survival Rate; Treatment Outcome

2018
Fluticasone, Azithromycin, and Montelukast Treatment for New-Onset Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2016, Volume: 22, Issue:4

    Topics: Acetates; Adult; Aged; Anti-Inflammatory Agents; Azithromycin; Bronchiolitis Obliterans; Cyclopropanes; Disease Progression; Fluticasone; Forced Expiratory Volume; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Lung; Male; Middle Aged; Quality of Life; Quinolines; Sulfides; Survival Analysis; Transplantation, Homologous; Treatment Outcome

2016

Other Studies

4 other study(ies) available for phenyl acetate and Bronchiolitis, Exudative

ArticleYear
Therapeutic effect of budesonide/formoterol, montelukast and N-acetylcysteine for bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation.
    Respiratory research, 2016, 05-26, Volume: 17, Issue:1

    Topics: Acetates; Acetylcysteine; Adrenergic beta-2 Receptor Agonists; Adult; Anti-Inflammatory Agents; Antioxidants; Bronchiolitis Obliterans; Bronchodilator Agents; Budesonide, Formoterol Fumarate Drug Combination; Cyclopropanes; Drug Therapy, Combination; Female; Forced Expiratory Volume; Glucocorticoids; Hematopoietic Stem Cell Transplantation; Humans; Leukotriene Antagonists; Lung; Male; Middle Aged; Quinolines; Recovery of Function; Retrospective Studies; Sulfides; Time Factors; Treatment Outcome; Vital Capacity

2016
Lung Function Trajectory in Bronchiolitis Obliterans Syndrome after Allogeneic Hematopoietic Cell Transplant.
    Annals of the American Thoracic Society, 2016, Volume: 13, Issue:11

    Topics: Acetates; Adolescent; Adult; Aged; Anti-Inflammatory Agents; Azithromycin; Bronchiolitis Obliterans; Cyclopropanes; Drug Therapy, Combination; Female; Fluticasone; Forced Expiratory Volume; Hematopoietic Stem Cell Transplantation; Humans; Kaplan-Meier Estimate; Linear Models; Lung; Male; Middle Aged; Multivariate Analysis; Postoperative Complications; Prospective Studies; Quinolines; Retrospective Studies; Sulfides; Survival Rate; United States; Young Adult

2016
Fluticasone, azithromycin and montelukast therapy in reducing corticosteroid exposure in bronchiolitis obliterans syndrome after allogeneic hematopoietic SCT: a case series of eight patients.
    Bone marrow transplantation, 2011, Volume: 46, Issue:10

    Topics: Acetates; Adrenal Cortex Hormones; Adult; Androstadienes; Azithromycin; Bronchiolitis Obliterans; Cyclopropanes; Female; Fluticasone; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Quinolines; Retrospective Studies; Sulfides; Transplantation, Homologous; Young Adult

2011
Montelukast for bronchiolitis obliterans syndrome after lung transplantation: a pilot study.
    Transplant international : official journal of the European Society for Organ Transplantation, 2011, Volume: 24, Issue:7

    Topics: Acetates; Azithromycin; Bronchiolitis Obliterans; Cyclopropanes; Female; Forced Expiratory Volume; Humans; Leukotriene Antagonists; Lung Transplantation; Male; Middle Aged; Pilot Projects; Quinolines; Sulfides; Treatment Outcome

2011